| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Kyle Hewitt, Xu-Feng Huan. Comment on "Impact of clozapine on the expression of miR-675-3p in plasma exosomes derived from patients with schizophrenia". The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry. 2024-05-02. PMID:38693660. |
comment on "impact of clozapine on the expression of mir-675-3p in plasma exosomes derived from patients with schizophrenia". |
2024-05-02 |
2024-05-04 |
Not clear |
| Brooke Gessner, Michelle Carter, Kiana Rahnama, Alberto Almeida, Colleen Borralho, Tamara Mihic, Joan C Y Ng, Joseph H Puyat, Angela Russolillo, Katelyn C Halpap. Clozapine clinical toolkit optimizes inpatient clozapine monitoring. The mental health clinician. vol 14. issue 2. 2024-05-02. PMID:38694883. |
clozapine is the most effective antipsychotic in the management of treatment-resistant schizophrenia; however, its use is challenging due to the risk of severe adverse effects. |
2024-05-02 |
2024-05-04 |
Not clear |
| Yun Tien, Xi-Yu Wang, Shang-Chien Huang, Hsiang-Ping Huan. Beneficial Effects of Concomitant Long-Acting Injectable Antipsychotics on Time to Rehospitalization in Patients With Treatment-Resistant Schizophrenia Receiving Clozapine: A Retrospective Cohort Study. The Journal of clinical psychiatry. vol 85. issue 2. 2024-05-02. PMID:38696112. |
beneficial effects of concomitant long-acting injectable antipsychotics on time to rehospitalization in patients with treatment-resistant schizophrenia receiving clozapine: a retrospective cohort study. |
2024-05-02 |
2024-05-04 |
Not clear |
| Jose M Rubio, John M Kane, Antti Tanskanen, Jari Tiihonen, Heidi Taipal. Long-term persistence of the risk of agranulocytosis with clozapine compared with other antipsychotics: a nationwide cohort and case-control study in Finland. The lancet. Psychiatry. 2024-05-02. PMID:38697177. |
agranulocytosis is a life-threatening side-effect of clozapine, the only approved drug for treatment-resistant schizophrenia. |
2024-05-02 |
2024-05-05 |
Not clear |
| Ofer Agid, Benedicto Crespo-Facorro, Andrea de Bartolomeis, Andrea Fagiolini, Oliver D Howes, Niko Seppälä, Christoph U Correl. Overcoming the barriers to identifying and managing treatment-resistant schizophrenia and to improving access to clozapine: A narrative review and recommendation for clinical practice. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology. vol 84. 2024-04-24. PMID:38657339. |
overcoming the barriers to identifying and managing treatment-resistant schizophrenia and to improving access to clozapine: a narrative review and recommendation for clinical practice. |
2024-04-24 |
2024-04-28 |
Not clear |
| Ofer Agid, Benedicto Crespo-Facorro, Andrea de Bartolomeis, Andrea Fagiolini, Oliver D Howes, Niko Seppälä, Christoph U Correl. Overcoming the barriers to identifying and managing treatment-resistant schizophrenia and to improving access to clozapine: A narrative review and recommendation for clinical practice. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology. vol 84. 2024-04-24. PMID:38657339. |
clozapine is the only approved antipsychotic for treatment-resistant schizophrenia (trs). |
2024-04-24 |
2024-04-28 |
Not clear |
| Emilio Fernandez-Egea, Shanquan Chen, Estela Sangüesa, Patricia Gassó, Marjan Biria, James Plaistow, Isaac Jarratt-Barnham, Nuria Segarra, Sergi Mas, Maria-Pilar Ribate, Cristina B García, Naomi A Fineberg, Yulia Worbe, Rudolf N Cardinal, Trevor W Robbin. The role of psychosis and clozapine load in excessive checking in treatment-resistant schizophrenia: longitudinal observational study. The British journal of psychiatry : the journal of mental science. vol 224. issue 5. 2024-04-23. PMID:38652060. |
the role of psychosis and clozapine load in excessive checking in treatment-resistant schizophrenia: longitudinal observational study. |
2024-04-23 |
2024-04-26 |
Not clear |
| Shimeng Jiao, Nana Li, Ting Cao, Liwei Wang, Hui Chen, Chenquan Lin, Hualin Ca. Differential impact of intermittent versus continuous treatment with clozapine on fatty acid metabolism in the brain of an MK-801-induced mouse model of schizophrenia. Progress in neuro-psychopharmacology & biological psychiatry. 2024-04-20. PMID:38642730. |
differential impact of intermittent versus continuous treatment with clozapine on fatty acid metabolism in the brain of an mk-801-induced mouse model of schizophrenia. |
2024-04-20 |
2024-04-23 |
mouse |
| Shimeng Jiao, Nana Li, Ting Cao, Liwei Wang, Hui Chen, Chenquan Lin, Hualin Ca. Differential impact of intermittent versus continuous treatment with clozapine on fatty acid metabolism in the brain of an MK-801-induced mouse model of schizophrenia. Progress in neuro-psychopharmacology & biological psychiatry. 2024-04-20. PMID:38642730. |
we thus utilized an mk-801-induced animal model of schizophrenia to evaluate whether two treatment strategies of clozapine would affect drug response and fa metabolism differently in the brain. |
2024-04-20 |
2024-04-23 |
mouse |
| Xiding Yang, Qiangyong Yan, Lingfeng Yang, Jingjing Li, Xiao Fan, Jindong Chen, Haishan Wu, Yongyu Yang, Ronghua Zhu, Pingfei Fan. Effect of propranolol on pharmacokinetics of clozapine in schizophrenic patients: a meta-analysis. European journal of clinical pharmacology. 2024-04-19. PMID:38639762. |
clozapine is the effective therapy for treatment-refractory schizophrenia. |
2024-04-19 |
2024-04-21 |
Not clear |
| Kohei Kitagawa, Shusuke Uekusa, Yuki Hanai, Itsuki Kimura, Masaru Tsukahara, Azusa Kagawa, Kenji Sasaoka, Yui Sakishiro, Ayaka Miyake, Yuki Watanabe, Daiki Baba, Masafumi Kodama, Yoshiki Kishi, Norihito Yamada, Takashi Yoshio, Kazuhiro Matsu. Changes in psychopharmacotherapy for patients with schizophrenia in a psychiatric institution in Japan: A 12-year prescription survey pre- and post-introduction of clozapine. Asian journal of psychiatry. vol 96. 2024-04-19. PMID:38640549. |
changes in psychopharmacotherapy for patients with schizophrenia in a psychiatric institution in japan: a 12-year prescription survey pre- and post-introduction of clozapine. |
2024-04-19 |
2024-04-22 |
Not clear |
| Kohei Kitagawa, Shusuke Uekusa, Yuki Hanai, Itsuki Kimura, Masaru Tsukahara, Azusa Kagawa, Kenji Sasaoka, Yui Sakishiro, Ayaka Miyake, Yuki Watanabe, Daiki Baba, Masafumi Kodama, Yoshiki Kishi, Norihito Yamada, Takashi Yoshio, Kazuhiro Matsu. Changes in psychopharmacotherapy for patients with schizophrenia in a psychiatric institution in Japan: A 12-year prescription survey pre- and post-introduction of clozapine. Asian journal of psychiatry. vol 96. 2024-04-19. PMID:38640549. |
we aimed to investigate the changes in psychopharmacotherapy in patients with schizophrenia over 12 years pre- and post-introduction of clozapine to clarify how psychopharmacotherapy for patients with schizophrenia has changed with the introduction of clozapine. |
2024-04-19 |
2024-04-22 |
Not clear |
| Kohei Kitagawa, Shusuke Uekusa, Yuki Hanai, Itsuki Kimura, Masaru Tsukahara, Azusa Kagawa, Kenji Sasaoka, Yui Sakishiro, Ayaka Miyake, Yuki Watanabe, Daiki Baba, Masafumi Kodama, Yoshiki Kishi, Norihito Yamada, Takashi Yoshio, Kazuhiro Matsu. Changes in psychopharmacotherapy for patients with schizophrenia in a psychiatric institution in Japan: A 12-year prescription survey pre- and post-introduction of clozapine. Asian journal of psychiatry. vol 96. 2024-04-19. PMID:38640549. |
the increase in clozapine prescription has contributed to an increased rate of antipsychotic monotherapy and a decreased rate of polypharmacy, promoting the optimization of schizophrenia medication. |
2024-04-19 |
2024-04-22 |
Not clear |
| Kohei Kitagawa, Shusuke Uekusa, Yuki Hanai, Itsuki Kimura, Masaru Tsukahara, Azusa Kagawa, Kenji Sasaoka, Yui Sakishiro, Ayaka Miyake, Yuki Watanabe, Daiki Baba, Masafumi Kodama, Yoshiki Kishi, Norihito Yamada, Takashi Yoshio, Kazuhiro Matsu. Changes in psychopharmacotherapy for patients with schizophrenia in a psychiatric institution in Japan: A 12-year prescription survey pre- and post-introduction of clozapine. Asian journal of psychiatry. vol 96. 2024-04-19. PMID:38640549. |
clozapine therapy should be further promoted in japan to reduce treatment-resistant schizophrenia due to polypharmacy as much as possible. |
2024-04-19 |
2024-04-22 |
Not clear |
| Hasan Çağın Lenk, Robert Løvsletten Smith, Kevin S O'Connell, Ole A Andreassen, Espen Molde. Rapid Metabolism Underlying Subtherapeutic Serum Levels of Atypical Antipsychotics Preceding Clozapine Treatment: A Retrospective Analysis of Real-World Data. CNS drugs. 2024-04-18. PMID:38635089. |
adequate antipsychotic treatment intensity is required before diagnosing resistant schizophrenia and initiating clozapine treatment. |
2024-04-18 |
2024-04-20 |
Not clear |
| Merve Direktor, Peter Gass, Dragos Int. Understanding the therapeutic action of antipsychotics: from molecular to cellular targets with focus on the islands of Calleja. The international journal of neuropsychopharmacology. 2024-04-17. PMID:38629703. |
here we discuss results suggesting a main role of the islands of calleja, still poorly studied gabaergic granule cell clusters in the ventral striatum, as cellular targets of several innovative atypical antipsychotics (clozapine, cariprazine and xanomeline/emraclidine) effective in treating also negative symptoms of schizophrenia. |
2024-04-17 |
2024-04-19 |
Not clear |
| Archana Mishra, Rituparna Maiti, Biswa Ranjan Mishra, Anand Srinivasa. Augmentation Strategies for Partial or Non-responders to Clozapine in Patients with Schizophrenia: A Bayesian Network Meta-analysis of Randomized Controlled Trials. Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology. vol 22. issue 2. 2024-04-16. PMID:38627071. |
augmentation strategies for partial or non-responders to clozapine in patients with schizophrenia: a bayesian network meta-analysis of randomized controlled trials. |
2024-04-16 |
2024-04-19 |
Not clear |
| Vicent Llorca-Bofí, Miquel Bioque, Santiago Madero, Andrea Mallorquí, Cristina Oliveira, Marina Garriga, Eduard Parellada, Clemente García-Riz. Blood Cell Count Ratios at Baseline are Associated with Initial Clinical Response to Clozapine in Treatment-Resistant, Clozapine-Naïve, Schizophrenia-Spectrum Disorder. Pharmacopsychiatry. 2024-04-15. PMID:38621701. |
clozapine is the recommended treatment for managing treatment-resistant schizophrenia (trs), and immunological mechanisms may be involved in its unique antipsychotic efficacy. |
2024-04-15 |
2024-04-18 |
Not clear |
| Javeria Sahib Din, Ernesto Navarro Garcia, Hiba Al-Rubaye, Carlos Julia. Knee Buckling as an Atypical Adverse Effect of Clozapine: A Case Report. Cureus. vol 16. issue 3. 2024-04-10. PMID:38595866. |
clozapine has become a widely popular and effective medication in the treatment of refractory schizophrenia and refractory bipolar disorder. |
2024-04-10 |
2024-04-12 |
Not clear |
| Nuree Kang, Hee-Soo Yoon, Se Hyun Kim, Jae Hoon Jeong, Minah Kim, Jun Soo Kwo. Comparative Study of the Efficacy and Side Effects of Brand-Name and Generic Clozapine for Long-Term Maintenance Treatment Among Korean Patients With Schizophrenia: A Retrospective Naturalistic Mirror-Image Study. Psychiatry investigation. vol 21. issue 3. 2024-04-03. PMID:38569589. |
comparative study of the efficacy and side effects of brand-name and generic clozapine for long-term maintenance treatment among korean patients with schizophrenia: a retrospective naturalistic mirror-image study. |
2024-04-03 |
2024-04-06 |
Not clear |